Tissue distribution and excretion of 125I-lidamycin in mice and rats

World Journal of Gastroenterology

Volumn 11, Issue 21, 2005, Pages 3281-3284

  Liu, You Ping ^a,b   Li, Quan Sheng ^a   Huang, Yu Rong ^a   Liu, Chang Xiao ^a  

^a TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

C 1027; Distribution; Excretion; Lidamycin; RA method; TCA RA method

Indexed keywords

ANTIBIOTIC C 1027; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG TISSUE LEVEL; FECES ANALYSIS; MOUSE; NONHUMAN; RADIOACTIVITY; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; URINARY EXCRETION;

EID: 22144490235     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i21.3281     Document Type: Article

References (17)

1. Hu JL, Xue YC, Xie MY, Zhang R, Otani T, Minami Y, Yamada Y, Marunaka T. A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot 1988; 41: 1575-1579
2. Otani T, Minami Y, Marunaka T, Zhang R, Xie MY. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties. J Antibiot 1988; 41: 1580-1585
3. Zhen YS, Ming XY, Yu B, Otani T, Saito H, Yamada Y. A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity. J Antibiot 1989; 42: 1294-1298
4. Matsumoto T, Okuno Y, Sugiura Y. Specific interaction between a novel enediyne chromophore and apoprotein in macromolecular antitumor antibiotic C-1027. Biochem Biophys Res Commun 1993; 195: 659-666
5. Otani T. Conformation studies on and assessment by spectral analysis of the protein-chromophore interaction of the macromolecular antitumor antibiotic C-1027. J Antibiot 1993; 46: 791-802
6. He QY, Jiang B, Li DD, Zhen YS. Effects of lidamycin on apoptotic gene expressions and cytoskeleton in human hepatoma bel-7402 cells. Aizheng 2002; 21: 351-355
7. Cui DP, Wang Z, Li DD. Effect of lidamycin on the expression of genes involved in invasion regulation in HCT-8 human colon cancer cells. Yaoxue Xuebao 2001; 36: 246-249
8. Liu JS, Kuo SR, Yin X, Beerman TA, Melendy T. DNA damage by the enediyne C-1027 results in the inhibition of DNA replication by loss of replication protein A function and activation of DNA-dependent protein kinase. Biochemistry 2001; 40: 14661-14668
9. Shao RG, Zhen YS. Relationship between the molecular composition of C1027, a new macromolecular antibiotic with enediyne chromophore, and its antitumor activity. Yaoxue Xuebao 1995; 30: 336-342
10. Zhou CS, Xu LN, Jiang M, Zhen YS. A monoclonal antibody directed against an enediyne antitumor antibiotic and its preliminary application. Yaoxue Xuebao 1997; 32: 28-32
11. Xu YJ, Li DD, Zhen YS. Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells. Cancer Chemother Pharmacol 1990; 27: 41-46
12. Wang Z, He Q, Liang Y, Wang D, Li YY, Li D. Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells. Biochem Pharmacol 2003; 65: 1767-1775
13. Totsuka R, Aizawa Y, Uesugi M, Okuno Y, Matsumoto T, Sugiura Y. RNA cleavage by C-1027 chromophore, an enediyne antitumor antibiotic: high selectivity to an anticodon arm. Biochem Biophys Res Commun 1995; 208: 168-173
14. Tang ZM, Liu XW, Xu LP, Shan CW, Song QS. Pharmacokinetics and tissue distribution of human recombinant interleukin-2 in mice. Zhongguo Yaoli Xuebao 1994; 15: 51-56
15. Shah VP, Midha KK, Dighe S. Mcgilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, Mcdowall RD, Pittman KA, Spector S. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Pharcokinet 1991; 16: 249-255
16. Liu CX, Wei GL, Li QS. Methodology study of validation for bioanalysis in studies on pharmacokinetics and bioavailability. Asian J Drug Metab Pharcokinet 2001; 1: 279-286
17. Pannell R, Gurewich V. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Blood 1986; 67: 1215-1223